Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Akari Therapeutics ADR (AKTX)

Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Akari Therapeutics ADR 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 GBR

www.akaritx.com Employees: 12 P: 929-274-7510

Description:

Akari Therapeutics PLC is a biopharmaceutical company. It focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The Company's lead drug consist of Coversin is a recombinant small protein, which acts on complement component-C5, preventing release of C5a and formation of C5b-9. Akari Therapeutics PLC, formerly known as Celsus Therapeutics Plc, is based in London, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 15,789
Enterprise Value, $K 11,939
Shares Outstanding, K 12,145
Annual Sales, $ 0 K
Annual Net Income, $ -10,010 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,900 K
EBIT, $ -18,880 K
EBITDA, $ -18,880 K
60-Month Beta 0.79
% of Insider Shareholders 38.90%
% of Institutional Shareholders 5.06%
Float, K 7,421
% Float 61.10%
Short Volume Ratio 0.43

Growth:

1-Year Return -59.88%
3-Year Return -95.83%
5-Year Return -96.56%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.71%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 11/19/24
Next Earnings Date 05/06/24
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 08/17/23

AKTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.55
Interest Coverage -0.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar